About Altucell
Altucell is a Healthcare company based in Babylon (United States) founded in 2010 by Gary R Harlem, and was acquired by Generex Biotechnology in September 2019. Regenerative therapies for neurodegenerative and autoimmune diseases are developed. Its chief executive, as recorded, is Gary R Harlem. Altucell offers products and services including Microencapsulation and Cell Technology. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Diversified. Its legal entity is Altucell Therapeutics. Its competitors include Avidity Biosciences, Sutro Biopharma and Antheia; 3 of its 3 listed competitors have raised funding.
Company details
Altucell was founded in 2010 and is headquartered in Babylon, United States. Regenerative therapies are developed by the company for autoimmune diseases, diabetes, and neurodegenerative conditions. A patented micro-encapsulation technology is utilized to deliver cell-based treatments protected from immune attacks. Operations focus on biotechnology applications in the healthcare sector, with emphasis on therapeutic advancements.
- Headquarters Babylon, United States
- Founders Gary R Harlem
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website altucell.com
- Social X
- Acquired by Generex Biotechnology (Sep 2019)
- Legal Name Altucell Therapeutics
- Investors
- Acquired byGenerex Biotechnology
(Sep 2019)
Products & Services of Altucell
Altucell offers a comprehensive portfolio of products and services, including Microencapsulation and Cell Technology.
Technology for encapsulating cells to treat autoimmune and diabetes conditions.
Platform for developing therapies targeting neurodegenerative and related diseases.
Investors in Altucell
Altucell has secured backing from 1 investor. Prominent investors backing the company include Generex Biotechnology.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Technologies for large molecule drug delivery are developed. | 1983 | generex.com | Miramar, United States |
Investor details for Altucell
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Altucell
1 people are tracked at Altucell (1 in leadership).
| Name | Role | Group |
|---|---|---|
Gary R Harlem | Founder & CEO | Leadership |
Complete people profiles for Altucell
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Altucell
2 dated milestones of Altucell across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Altucell is founded.
- Exit Acquired by Generex Biotechnology.
Competitors of Altucell
Altucell has 3 listed competitors in our database, 3 of them funded. They include Avidity Biosciences, Sutro Biopharma and Antheia.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| sutrobio.com | 2003 | United States | $171.85M | 235 | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | |
| antheia.bio | 2013 | Palo Alto, United States | $152.37M | 50 | Yeast cells are genetically engineered to produce medicinal products. |
Detailed competitors of Altucell
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Altucell (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Altucell
Altucell was founded in 2010.
Altucell is headquartered in Babylon, United States. It is registered at Babylon, New York, United States.
Gary R Harlem is the CEO of Altucell, as recorded in our data. They have also founded this company.
Altucell was founded in 2010 and is headquartered in Babylon, United States. Regenerative therapies are developed by the company for autoimmune diseases, diabetes, and neurodegenerative conditions. A patented micro-encapsulation technology is utilized to deliver cell-based treatments protected from immune attacks. Operations focus on biotechnology applications in the healthcare sector, with emphasis on therapeutic advancements.
Altucell's top competitors include Sutro Biopharma, Avidity Biosciences and Antheia.
Altucell offers Microencapsulation and Cell Technology.
Altucell has 1 investor. Key investors include Generex Biotechnology.
Altucell operates through Altucell Therapeutics.
Yes. Altucell was acquired by Generex Biotechnology in September 2019.